Sign In
Buy SINT
$2.24
+0.160 (+7.69%)
At Close: Jun 03, 2026
SALT LAKE CITY, Utah, June 03, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced biomaterials company focused on developing silicon nitri
SINTX Technologies to Present at the LD Micro Invitational XVI Conference
03:30pm, Sunday, 17'th May 2026
Salt Lake City, Utah--(Newsfile Corp. - May 17, 2026) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a medical technology company focused on advanced ceramics and silicon nitrid
Sintx Technologies (NASDAQ:SINT) versus Vasamed (OTCMKTS:VSMD) Critical Review
02:29am, Sunday, 19'th Apr 2026
Sintx Technologies (NASDAQ: SINT - Get Free Report) and Vasamed (OTCMKTS:VSMD - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies base
Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
07:30am, Thursday, 19'th Mar 2026
Major clinical milestone marks SINTX's entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platform
Critical Analysis: OPKO Health (NASDAQ:OPK) vs. Sintx Technologies (NASDAQ:SINT)
01:59am, Friday, 27'th Feb 2026
OPKO Health (NASDAQ: OPK - Get Free Report) and Sintx Technologies (NASDAQ: SINT - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two busines
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms
08:30am, Wednesday, 18'th Feb 2026
Appointment supports acceleration of revenue opportunities from SiNERGY ™ silicon nitride devices and antipathogenic fibrous material technologies
SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5
09:00am, Thursday, 29'th Jan 2026
SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon-nit
Analyzing LivaNova (NASDAQ:LIVN) & Sintx Technologies (NASDAQ:SINT)
02:26am, Friday, 12'th Dec 2025
Sintx Technologies (NASDAQ: SINT - Get Free Report) and LivaNova (NASDAQ: LIVN - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based
SINTX Technologies to Participate in Sidoti & Company Investor Conference
09:00am, Monday, 08'th Dec 2025
SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), today announced that management will be presenting at Sidoti and Company's Y
Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an
Clinical evaluation of the product by design surgeons completed, driving early commercial momentum SALT LAKE CITY, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“S
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
07:00am, Monday, 20'th Oct 2025
FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (�
What Makes SINTX TECHNOLOGIES, INC. (SINT) a Strong Momentum Stock: Buy Now?
01:01pm, Thursday, 16'th Oct 2025
Does SINTX TECHNOLOGIES, INC. (SINT) have what it takes to be a top stock pick for momentum investors?
SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics
07:00am, Tuesday, 14'th Oct 2025
New method patent expands SINTX's infection-prevention IP portfolio in $30 Billion Total Addressable Market U.S. Patent Notice of Allowance reinforces competitive advantage and enables broader licensi
